Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis

Purpose: Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents including ranibizumab and aflibercept are used to treat patients with ocular disorders such as neovascular age-related macular degeneration (nAMD); however, the injections are associated with rare instances of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ophthalmic Epidemiol
Päätekijät: Souied, Eric H., Dugel, Pravin U., Ferreira, Alberto, Hashmonay, Ron, Lu, Jingsong, Kelly, Simon P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2016
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4819836/
https://ncbi.nlm.nih.gov/pubmed/26855278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09286586.2015.1090004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia